These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30277567)

  • 21. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins in Older Danes: Factors Associated With Discontinuation Over the First 4 Years of Use.
    Thompson W; Jarbøl DE; Haastrup P; Nielsen JB; Pottegård A
    J Am Geriatr Soc; 2019 Oct; 67(10):2050-2057. PubMed ID: 31335968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population.
    Mortensen MB; Nordestgaard BG
    Ann Intern Med; 2018 Jan; 168(2):85-92. PubMed ID: 29297004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Starting primary prevention earlier with statins.
    Robinson JG
    Am J Cardiol; 2014 Nov; 114(9):1437-42. PubMed ID: 25205631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults.
    Montgomery S; Miedema MD; Dodson JA
    Heart; 2022 Jun; 108(14):1090-1097. PubMed ID: 34764212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current drug treatment of hyperlipidemia in older adults.
    Dixon DL; Donohoe KL; Ogbonna KC; Barden SM
    Drugs Aging; 2015 Feb; 32(2):127-38. PubMed ID: 25637391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The causes and effects of socio-demographic exclusions from clinical trials.
    Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P
    Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Critical Review of the Consensus Statement from the European Atherosclerosis Society Consensus Panel 2017.
    Okuyama H; Hamazaki T; Hama R; Ogushi Y; Kobayashi T; Ohara N; Uchino H
    Pharmacology; 2018; 101(3-4):184-218. PubMed ID: 29353277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.
    Lloyd-Jones DM; Braun LT; Ndumele CE; Smith SC; Sperling LS; Virani SS; Blumenthal RS
    Circulation; 2019 Jun; 139(25):e1162-e1177. PubMed ID: 30586766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.
    Karmali KN; Lloyd-Jones DM; Berendsen MA; Goff DC; Sanghavi DM; Brown NC; Korenovska L; Huffman MD
    JAMA Cardiol; 2016 Jun; 1(3):341-9. PubMed ID: 27438118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women.
    Ma Y; Persuitte GM; Andrews C; Hovey KM; LaMonte MJ; Culver AL; Manson JE; Phillips LS; Liu S; Eaton C; Martin LW; Howard BV; Balasubramanian R; Bird CE; Ockene IS; Sturgeon SR; Ockene JK; Tinker L; Nassir R; Rossouw J
    Eur J Epidemiol; 2016 Aug; 31(8):747-61. PubMed ID: 27188186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.
    Anderson JL; Knowlton KU; May HT; Bair TL; Armstrong SO; Lappé DL; Muhlestein JB
    J Clin Lipidol; 2018; 12(4):1008-1018.e1. PubMed ID: 29703626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus.
    Tan M; MacEachern MP
    Clin Geriatr Med; 2020 Aug; 36(3):457-476. PubMed ID: 32586475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addressing statin adverse effects in the clinic: the 5 Ms.
    Katz DH; Intwala SS; Stone NJ
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):533-42. PubMed ID: 24770611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Statins Prescribed for Primary and Secondary Prevention and Major Adverse Cardiac Events among Older Adults with Frailty: A Systematic Review.
    Hale M; Zaman H; Mehdizadeh D; Todd O; Callaghan H; Gale CP; Clegg A
    Drugs Aging; 2020 Nov; 37(11):787-799. PubMed ID: 32929609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimated Impact of US Preventive Services Task Force Recommendations on Use and Cost of Statins for Cardiovascular Disease Prevention.
    Ngo-Metzger Q; Zuvekas SH; Bierman AS
    J Gen Intern Med; 2018 Aug; 33(8):1317-1323. PubMed ID: 29855861
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.